Copyright Reports & Markets. All rights reserved.

Global Lentivirus Particle Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Lentivirus Particle by Type
    • 1.3.1 Overview: Global Lentivirus Particle Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Lentivirus Particle Consumption Value Market Share by Type in 2025
    • 1.3.3 Custom-made
    • 1.3.4 Pre-made
  • 1.4 Global Lentivirus Particle Market by Application
    • 1.4.1 Overview: Global Lentivirus Particle Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Gene Expression
    • 1.4.3 Gene Editing
    • 1.4.4 Cell Line Development
    • 1.4.5 Gene Therapy
    • 1.4.6 Others
  • 1.5 Global Lentivirus Particle Market Size & Forecast
  • 1.6 Global Lentivirus Particle Market Size and Forecast by Region
    • 1.6.1 Global Lentivirus Particle Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Lentivirus Particle Market Size by Region, (2021-2032)
    • 1.6.3 North America Lentivirus Particle Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Lentivirus Particle Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Lentivirus Particle Market Size and Prospect (2021-2032)
    • 1.6.6 South America Lentivirus Particle Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Lentivirus Particle Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 AMSBIO
    • 2.1.1 AMSBIO Details
    • 2.1.2 AMSBIO Major Business
    • 2.1.3 AMSBIO Lentivirus Particle Product and Solutions
    • 2.1.4 AMSBIO Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AMSBIO Recent Developments and Future Plans
  • 2.2 Creative Biogene
    • 2.2.1 Creative Biogene Details
    • 2.2.2 Creative Biogene Major Business
    • 2.2.3 Creative Biogene Lentivirus Particle Product and Solutions
    • 2.2.4 Creative Biogene Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Creative Biogene Recent Developments and Future Plans
  • 2.3 Cellomics Technology
    • 2.3.1 Cellomics Technology Details
    • 2.3.2 Cellomics Technology Major Business
    • 2.3.3 Cellomics Technology Lentivirus Particle Product and Solutions
    • 2.3.4 Cellomics Technology Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Cellomics Technology Recent Developments and Future Plans
  • 2.4 GenTarget
    • 2.4.1 GenTarget Details
    • 2.4.2 GenTarget Major Business
    • 2.4.3 GenTarget Lentivirus Particle Product and Solutions
    • 2.4.4 GenTarget Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GenTarget Recent Developments and Future Plans
  • 2.5 Takara Bio
    • 2.5.1 Takara Bio Details
    • 2.5.2 Takara Bio Major Business
    • 2.5.3 Takara Bio Lentivirus Particle Product and Solutions
    • 2.5.4 Takara Bio Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Takara Bio Recent Developments and Future Plans
  • 2.6 GeneCopoeia
    • 2.6.1 GeneCopoeia Details
    • 2.6.2 GeneCopoeia Major Business
    • 2.6.3 GeneCopoeia Lentivirus Particle Product and Solutions
    • 2.6.4 GeneCopoeia Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GeneCopoeia Recent Developments and Future Plans
  • 2.7 OriGene
    • 2.7.1 OriGene Details
    • 2.7.2 OriGene Major Business
    • 2.7.3 OriGene Lentivirus Particle Product and Solutions
    • 2.7.4 OriGene Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 OriGene Recent Developments and Future Plans
  • 2.8 GenScript
    • 2.8.1 GenScript Details
    • 2.8.2 GenScript Major Business
    • 2.8.3 GenScript Lentivirus Particle Product and Solutions
    • 2.8.4 GenScript Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 GenScript Recent Developments and Future Plans
  • 2.9 Addgene
    • 2.9.1 Addgene Details
    • 2.9.2 Addgene Major Business
    • 2.9.3 Addgene Lentivirus Particle Product and Solutions
    • 2.9.4 Addgene Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Addgene Recent Developments and Future Plans
  • 2.10 System Biosciences
    • 2.10.1 System Biosciences Details
    • 2.10.2 System Biosciences Major Business
    • 2.10.3 System Biosciences Lentivirus Particle Product and Solutions
    • 2.10.4 System Biosciences Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 System Biosciences Recent Developments and Future Plans
  • 2.11 BPS Bioscience
    • 2.11.1 BPS Bioscience Details
    • 2.11.2 BPS Bioscience Major Business
    • 2.11.3 BPS Bioscience Lentivirus Particle Product and Solutions
    • 2.11.4 BPS Bioscience Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 BPS Bioscience Recent Developments and Future Plans
  • 2.12 Charles River
    • 2.12.1 Charles River Details
    • 2.12.2 Charles River Major Business
    • 2.12.3 Charles River Lentivirus Particle Product and Solutions
    • 2.12.4 Charles River Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Charles River Recent Developments and Future Plans
  • 2.13 Santa Cruz Biotechnology
    • 2.13.1 Santa Cruz Biotechnology Details
    • 2.13.2 Santa Cruz Biotechnology Major Business
    • 2.13.3 Santa Cruz Biotechnology Lentivirus Particle Product and Solutions
    • 2.13.4 Santa Cruz Biotechnology Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Santa Cruz Biotechnology Recent Developments and Future Plans
  • 2.14 Sigma-Aldrich
    • 2.14.1 Sigma-Aldrich Details
    • 2.14.2 Sigma-Aldrich Major Business
    • 2.14.3 Sigma-Aldrich Lentivirus Particle Product and Solutions
    • 2.14.4 Sigma-Aldrich Lentivirus Particle Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Sigma-Aldrich Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Lentivirus Particle Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Lentivirus Particle by Company Revenue
    • 3.2.2 Top 3 Lentivirus Particle Players Market Share in 2025
    • 3.2.3 Top 6 Lentivirus Particle Players Market Share in 2025
  • 3.3 Lentivirus Particle Market: Overall Company Footprint Analysis
    • 3.3.1 Lentivirus Particle Market: Region Footprint
    • 3.3.2 Lentivirus Particle Market: Company Product Type Footprint
    • 3.3.3 Lentivirus Particle Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Lentivirus Particle Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Lentivirus Particle Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Lentivirus Particle Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Lentivirus Particle Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Lentivirus Particle Consumption Value by Type (2021-2032)
  • 6.2 North America Lentivirus Particle Market Size by Application (2021-2032)
  • 6.3 North America Lentivirus Particle Market Size by Country
    • 6.3.1 North America Lentivirus Particle Consumption Value by Country (2021-2032)
    • 6.3.2 United States Lentivirus Particle Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Lentivirus Particle Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Lentivirus Particle Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Lentivirus Particle Consumption Value by Type (2021-2032)
  • 7.2 Europe Lentivirus Particle Consumption Value by Application (2021-2032)
  • 7.3 Europe Lentivirus Particle Market Size by Country
    • 7.3.1 Europe Lentivirus Particle Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Lentivirus Particle Market Size and Forecast (2021-2032)
    • 7.3.3 France Lentivirus Particle Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Lentivirus Particle Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Lentivirus Particle Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Lentivirus Particle Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Lentivirus Particle Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Lentivirus Particle Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Lentivirus Particle Market Size by Region
    • 8.3.1 Asia-Pacific Lentivirus Particle Consumption Value by Region (2021-2032)
    • 8.3.2 China Lentivirus Particle Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Lentivirus Particle Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Lentivirus Particle Market Size and Forecast (2021-2032)
    • 8.3.5 India Lentivirus Particle Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Lentivirus Particle Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Lentivirus Particle Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Lentivirus Particle Consumption Value by Type (2021-2032)
  • 9.2 South America Lentivirus Particle Consumption Value by Application (2021-2032)
  • 9.3 South America Lentivirus Particle Market Size by Country
    • 9.3.1 South America Lentivirus Particle Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Lentivirus Particle Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Lentivirus Particle Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Lentivirus Particle Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Lentivirus Particle Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Lentivirus Particle Market Size by Country
    • 10.3.1 Middle East & Africa Lentivirus Particle Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Lentivirus Particle Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Lentivirus Particle Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Lentivirus Particle Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Lentivirus Particle Market Drivers
  • 11.2 Lentivirus Particle Market Restraints
  • 11.3 Lentivirus Particle Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Lentivirus Particle Industry Chain
  • 12.2 Lentivirus Particle Upstream Analysis
  • 12.3 Lentivirus Particle Midstream Analysis
  • 12.4 Lentivirus Particle Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Lentivirus Particle market size was valued at US$ 322 million in 2025 and is forecast to a readjusted size of US$ 428 million by 2032 with a CAGR of 4.2% during review period.
    Lentivirus particles have been widely used in biomedical research, particularly in the field of gene therapy and gene delivery. Lentiviruses, such as the human immunodeficiency virus (HIV), have been modified to be non-replicative and used as vectors to deliver genetic material into target cells. This delivery system enables the introduction of specific genes or genetic modifications into cells for various applications, including research, drug development, and potential therapeutic interventions.
    The lentivirus particle market has seen significant growth due to the expanding interest in gene therapy, gene editing, and other genetic research applications. Lentiviral vectors offer several advantages, including their ability to infect both dividing and non-dividing cells, stable gene expression over extended periods, and a broad range of target cell compatibility.
    Future development trends in the lentivirus particle market include:
    Enhanced Safety and Efficiency: Ongoing research aims to improve the safety and efficiency of lentivirus-based gene delivery systems. This includes developing new vector designs, modifying viral components, and optimizing transduction protocols.
    Targeted Delivery: Efforts are being made to enhance the specificity of lentiviral vectors by incorporating targeting ligands or using tissue-specific promoters. This enables more precise delivery of therapeutic genes to specific cell types or tissues.
    Large-Scale Production: As demand for lentivirus particles increases, there is a need for scalable and cost-effective production methods. Advances in large-scale manufacturing techniques and purification processes are anticipated to support the growth of the market.
    Regulatory Considerations: The lentivirus particle market is subject to regulatory oversight due to safety concerns associated with the use of viral vectors. Future developments may involve addressing regulatory requirements and guidelines to ensure safe and effective use of lentiviral-based therapies.
    This report is a detailed and comprehensive analysis for global Lentivirus Particle market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Lentivirus Particle market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Lentivirus Particle market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Lentivirus Particle market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Lentivirus Particle market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Lentivirus Particle
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Lentivirus Particle market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AMSBIO, Creative Biogene, Cellomics Technology, GenTarget, Takara Bio, GeneCopoeia, OriGene, GenScript, Addgene, System Biosciences, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Lentivirus Particle market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Custom-made
    Pre-made
    Market segment by Application
    Gene Expression
    Gene Editing
    Cell Line Development
    Gene Therapy
    Others
    Market segment by players, this report covers
    AMSBIO
    Creative Biogene
    Cellomics Technology
    GenTarget
    Takara Bio
    GeneCopoeia
    OriGene
    GenScript
    Addgene
    System Biosciences
    BPS Bioscience
    Charles River
    Santa Cruz Biotechnology
    Sigma-Aldrich
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Lentivirus Particle product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Lentivirus Particle, with revenue, gross margin, and global market share of Lentivirus Particle from 2021 to 2026.
    Chapter 3, the Lentivirus Particle competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Lentivirus Particle market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Lentivirus Particle.
    Chapter 13, to describe Lentivirus Particle research findings and conclusion.

    Buy now